MedDataX Logo

Effect of Cognitive Behavioral Therapy in OCD Highlighted by Neuropsychological Tests and MRI: Pathophysiology and Treatment Outcome Predictors

NCT ID: NCT00792038

Last Updated: 2012-08-02

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

88 participants

Study Classification

OBSERVATIONAL

Study Start Date

2009-01-31

Study Completion Date

2012-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

OCD patients are assessed before and after treatment using diagnostic tools, rating scales neuropsychological assessment and functional and structural MR-scans.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Obsessive-Compulsive Disorder

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Psychological tests Magnetic Resonance Imaging Cognitive therapy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

OCD patients

No interventions assigned to this group

2

Normal Controls

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1\. Steady state medication 3 months prior to the study

Exclusion Criteria

1. History of head trauma or other organic brain disease
2. Pregnancy.
3. Pacemaker or other ferromagnetic materials in the body.
4. Comorbid psychiatric illnesses assessed using SCAN- interview (30) other than moderate depression (Ham-D\<17) or anxiety disorders.
5. Antipsychotics
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Aarhus

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Tue BH Hartmann

Role: PRINCIPAL_INVESTIGATOR

Aarhus University Hospital, Risskov

Sanne Kjær

Role: STUDY_DIRECTOR

Aarhus University Hospital, Risskov

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Aarhus University Hospital, Risskov

Risskov, , Denmark

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Denmark

References

Explore related publications, articles, or registry entries linked to this study.

Vandborg SK, Hartmann TB, Bennedsen BE, Pedersen AD, Thomsen PH. Memory and executive functions in patients with obsessive-compulsive disorder. Cogn Behav Neurol. 2014 Mar;27(1):8-16. doi: 10.1097/WNN.0000000000000021.

Reference Type DERIVED
PMID: 24674961 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

M-20080161

Identifier Type: -

Identifier Source: org_study_id